Scott Kennedy
Vice President and Global Head of Biomarker Development, Translational Medicine
Novartis Institutes for Biomedical Research Inc. Markus Beier VP Strategy & IP
Comprehensive Biomarker Center GmbH |
| |
Daniel Chelsky
Chief Scientific Officer
Caprion |
| |
Kevin Cox
CEO
Imanova |
| |
Manfred Dietel
Professor, Institute of Pathologe
Charité – Universitätsmedizin Berlin |
| |
Hueseyin Firat
President & CEO
Firalis |
| |
Davina Gale
University of Cambridge |
| |
Joachim Greue
Partner
Bioscience Valuation BSV GmbH |
| |
Franz Hessel
Professor, Healthcare Management
SRH Hochschule Berlin |
| |
Graham Jackson
MRC Programme Leader
MRC Prion Unit and Department of Neurodegenerative Disease |
| |
Hans Lehrach
Max Planck Institute for Molecular Genetics |
| |
Michael Lutz
CEO
Lophius Biosciences |
| |
Heiko Niessen
Principal Translational Medicine Expert & Teamleader Clinical Imaging
Boehringer Ingelheim Pharma GmbH & Co. KG |
| |
Winfried Maerz
Synlab |
| |
Pierluigi Mauri
Doctor, Proteomics and Metabolomics
Institute for Biomedical Technologies (ITB-CNR) |
| |
Matthew Morrison
Biology Manager – UK
Medical Diagnostics |
| |
Christoph Petry
Geschaftsfuhrer and CEO
Sividon Diagnostics GmbH |
| |
Stephan Schwers
Head of Assay Technologies, Global Biomarkers - Clinical Sciences
Bayer AG |
| |
Birgitte Søgaard
Divisional Director, Clinical & Quantitative Pharmacology
H. Lundbeck A/S |
| |
Laszlo Takacs
Chief Scientific Officer
Biosystems International Kft. |
| |
Hans-Dieter Volk
Director, Institute of Medical Immunology & Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
Charité Universitätsmedizin |
| |
Paul Whittaker
Director and Unit Head Pre-Clinical Biomarkers
Novartis |
| |
Marion Wiesmann
Oncolgy Director
Novartis |
| |
Hai Zhang
Global Business Development
Roche |
| |
| |
| Please check back for updates: http://www.gtcbio.com/conference/biomarkers-europe-summit-speakers |